Results 171 to 180 of about 93,938 (325)

Unnatural Growth Hormone-Releasing Peptide Begets Natural Ghrelin [PDF]

, 2001
Cyril Y. Bowers
openalex   +2 more sources

Low‐ or No‐Energy Sweeteners and Body Weight Management: Dissecting a “Minor” Effect

Obesity Reviews, EarlyView.
ABSTRACT Nonnutritive sweeteners were introduced on the market over a century ago to displace the calories of added sugars in foods and beverages and, therefore, facilitate weight loss. In spite of their widespread use, obesity has reached epidemic proportions. The present paper addresses this apparent paradox. Low‐ or no‐energy sweeteners (LNES) are a
France Bellisle
wiley   +1 more source

Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa [PDF]

, 2001
Bärbel Otto, Ulrich Cuntz, E Fruehauf, Rainer Wawarta, C Folwaczny, Riepl Rl, ML Heiman, P. Lehnert, Manfred M. Fichter, M. Tschöp   +9 more
openalex   +1 more source

The effect of morning or evening fasted cycling on gastrointestinal function and appetite and metabolic responses in healthy males with overweight

Experimental Physiology, EarlyView.
Abstract Combining fasting with exercise may influence gastric emptying rate (GER) and provide benefits to weight management and metabolic health. Furthermore, the time of day in which exercise is performed may also influence these variables. The aim was to investigate if fasting or fed exercise at different times of the day would alter GER, appetite ...
Victoria J. McIver, Lewis R. Mattin, Gethin H. Evans, Adora M. W. Yau   +3 more
wiley   +1 more source

Incretin hormones and obesity

The Journal of Physiology, EarlyView.
Abstract figure legend The incretin system in obesity. The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) (yellow) and glucagon‐like peptide‐1 (GLP‐1) (blue) are produced by the proximal and distal small intestinal epithelium, where they are released postprandially into the bloodstream to modulate a myriad of physiological and ...
Constanza Alcaino, Frank Reimann, Fiona M. Gribble   +2 more
wiley   +1 more source

Organization of the Mouse Ghrelin Gene and Promoter: Occurrence of a Short Noncoding First Exon [PDF]

, 2001
Minoru Tanaka
openalex   +2 more sources

Oxyntomodulin physiology and its therapeutic development in obesity and associated complications

The Journal of Physiology, EarlyView.
Abstract figure legend Physiological influences of OXM and its emerging insights from evidence on bariatric surgery effects. CCK, cholecystokinin; FGF21, fibroblast growth factor 21; GLUT4, glucose transporter type 4; IRS1, insulin receptor substrate‐1; NNMT, nicotinamide N‐methyltransferase; OXM, oxyntomodulin Abstract Incretins, such as glucagon‐like
Martin T. W. Kueh, Ming Chuen Chong, Alexander D. Miras, Carel W. le Roux   +3 more
wiley   +1 more source

Ghrelin, A Novel Placental-Derived Hormone¹ [PDF]

, 2001
Oreste Gualillo, J. Eduardo Caminos, Montserrat Blanco, Tomás García‐Caballero, Masayasu Kojima, Kenji Kangawa, Carlos Diéguez, Felipe F. Casanueva   +7 more
openalex   +1 more source

Pep19: A Novel Approach for Reducing Visceral Fat and Improving Sleep Quality in Obese Adults—Results From an Early‐Stage Clinical Trial

Diabetes/Metabolism Research and Reviews, Volume 41, Issue 5, July 2025.
ABSTRACT Background Conformational‐sensitive antibodies were used to identify the orally active peptide DIIADDEPLT (Pep19) as an inverse agonist of cannabinoid type 1 receptor. Pep19 safely improved metabolic parameters in murine models of diet‐induced obesity, and in healthy dogs.
Andrea S. Heimann, Prachi Singh, Emer S. Ferro, Frank Greenway, Arnon Krongrad   +4 more
wiley   +1 more source

The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors1 [PDF]

, 2001
Márta Korbonits, Stephen A. Bustin, Masayasu Kojima, Suzanne Jordan, Eric F. Adams, David Lowe, Kenji Kangawa, Ashley Grossman   +7 more
openalex   +1 more source